Christophe Ricard
Europe, Geneve, Switzerland, Geneva
Description
Christophe Ricard CEO of OM Pharma
Investor Profile
Christophe Ricard has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Seed rounds (top funding stages).
- Majority of deals are located in France.
- Strong thematic focus on Biotechnology, Life Science, Medical Device.
Stage Focus
- Series B (50%)
- Seed (50%)
Country Focus
- France (100%)
Industry Focus
- Biotechnology
- Life Science
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
